The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, Thi-Ngoc-Lan Nguyen, Jaffar A. Al-Tawfiq, Dinh-Toi Chu

Predictors of response to biologic therapies in rheumatoid arthritis Lara M. Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez

Safety Profile of Biological Intravenous Therapy in a Rheumatoid Arthritis Patients Cohort. Clinical Nursing Monitoring (Sebiol Study) Hèctor Corominas, Lucinda Sánchez-Eslava, Guadalupe García, Isabel Padró, Cristina Aimarich, Joana Gonzàlez, Maria Franco, Emilia Mur, Silvia Sanchez, Glòria Roldán, Silvia Iniesta, Montse Sesma, Josefina Martín, Mari Carmen Rodriguez, Maria Rosa Capellan, Coral Gosálvez, Silvia Garcia-Diaz, Encarnación Sáez, Yolanda Luna, Pilar Plana